Lactobacillus salivarius

The oral cavity is not a sterile environment — and it never should be. Healthy gums and teeth exist not despite bacteria, but through a stable equilibrium between hundreds of species, each occupying its niche and collectively excluding pathogens. Lactobacillus salivarius is a native member of this ecosystem that may become depleted during dysbiosis — after antibiotics, stress, or poor hygiene.

What It Is

Lactobacillus salivarius is a gram-positive lactic acid bacterium isolated directly from human saliva and dental plaque. Unlike gut probiotics (L. rhamnosus GG, L. acidophilus) that merely transit through the mouth, L. salivarius is evolutionarily adapted to oral conditions: the oxygen environment, fluctuating pH, and contact with phenolic food compounds.

Key clinically studied strains:

• WB21 — used in a periodontal RCT (Shimauchi et al., 2008)
• TI 2711 — tested in patients with chronic periodontitis (Nishihara et al., 2014)
• K12B — included in multi-strain oral probiotic formulations

How It Works

Antagonism against pathogens via lactic acid. L. salivarius ferments carbohydrates to lactic acid, locally lowering pH. The apparent paradox — acid production promoting caries — is resolved by the selective nature of this action: L. salivarius operates in its ecological niche (near the mucosa), not on the enamel surface. S. mutans is outcompeted and displaced from its adhesion niche.

Bacteriocin-like substance production. Certain strains of L. salivarius (including WB21) produce low-molecular-weight antimicrobial peptides that suppress S. mutans, P. gingivalis, and F. nucleatum in vitro without significant effect on commensal species — S. salivarius, S. mitis, and others.

Competition for adhesion. Haukioja et al. (2006) demonstrated that L. salivarius shows high adhesion to buccal epithelial cells — comparable to pathogenic streptococci. This represents genuine competition for epithelial receptors, not merely transient passage through the oral cavity.

Immune modulation. Via TLR2/TLR4, L. salivarius induces anti-inflammatory cytokines (IL-10, TGF-β) in periodontal ligament cells and reduces IL-1β in GCF — the key biomarker of gingivitis severity.

Efficacy

Periodontal RCT, strain WB21 (PMID: 18363767)

Shimauchi et al. (2008): 66 adults with chronic periodontitis, 8-week randomized placebo-controlled study. The WB21 group (chewable tablets with 2×10⁸ CFU) showed statistically significant reductions in plaque index (PI), bleeding index (BI), and P. gingivalis proportion in subgingival smears compared to placebo. IL-1β in GCF was also reduced — direct evidence of anti-inflammatory activity.

Pilot RCT, strain TI 2711 (PMID: 24118767)

Nishihara et al. (2014): 22 patients with chronic periodontitis, 8 weeks. The TI 2711 group showed significantly greater reductions in probing depth (PD) and GI, plus significant suppression of T. forsythia by PCR analysis of subgingival flora.

Effect on salivary S. mutans

Caglar et al. (2005) studied probiotic-containing chewing gum versus control in 45 children. After 4 weeks of L. salivarius gum, salivary S. mutans levels dropped significantly (p < 0.05), comparable to the xylitol group. Xylitol and L. salivarius showed additive effects — a promising combination for anti-caries formulas.

Adhesion and survival in vitro (PMID: 16922747)

Among tested probiotic lactobacilli, L. salivarius showed the best adhesion to buccal cells specifically from the oral cavity (compared to gut strains), explaining its advantage over "food" probiotics in oral applications.

Safety

L. salivarius is a native oral species isolated from healthy human mouths. Its safety profile is comparable to L. reuteri:

• No virulence factors (no haemolysin, no capsule)
• No transferable antibiotic-resistance genes in clinically studied strains
• GRAS and QPS status for select strains
• Safe in randomized trials in children and elderly subjects

The one limitation: a smaller clinical trial base compared to L. reuteri or K12 — most studies are pilot or small-scale RCTs.

Role in the QDRO Formula

L. salivarius is best suited for multi-strain probiotic formulas alongside L. reuteri and K12, covering different ecological niches of the oral cavity:

• L. reuteri — active in the gingival sulcus (periodontal protection)
• K12 — throat and posterior tongue (halitosis, sore throats)
• L. salivarius — buccal epithelium and subgingival zone (caries, gingivitis)

Working dose in a multi-strain formula: 5×10⁷ CFU per strain, with a total load of 10⁸ CFU/dose.

Brand verdict: we use it — as the third component of the QDRO oral probiotic complex.

---

Sources:

• Caglar E et al. (2005). Effect of chewing gums containing xylitol or probiotic bacteria on salivary mutans streptococci levels. Clin Oral Investig. PMID: 15856357
• Shimauchi H et al. (2008). Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21. J Clin Periodontol. PMID: 18363767
• Nishihara T et al. (2014). Lactobacillus salivarius TI 2711 is a useful probiotic for periodontitis. Oral Dis. PMID: 24118767
• Näse L et al. (2001). Effect of long-term consumption of a probiotic bacterium in milk on dental caries in children. Caries Res. PMID: 11275674
• Haukioja A et al. (2006). Oral adhesion and survival of probiotic and other lactobacilli and bifidobacteria in vitro. Oral Microbiol Immunol. PMID: 16922747